IMRASGO
Live / Applied — First extension granted (statement of use) (as of 27 Oct 2025)
What this means for you
Not registered yet, but its 17 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98907173
- Mark type
- Stylized text
- Filed
- 17 Dec 2024
- Published for opposition
- 29 Apr 2025
- Attorney of record
- Jelena Libby
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 28 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2025 — SOU EXTENSION 1 GRANTED
- 27 Oct 2025 — SOU EXTENSION 1 FILED
- 27 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Mar 2025 — ASSIGNED TO EXAMINER
- 17 Dec 2024 — APPLICATION FILING RECEIPT MAILED
- 17 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Dec 2024 — NEW APPLICATION ENTERED